Piper Sandler lowered the firm’s price target on Core Laboratories to $18 from $21 on reduced EBITDA. The firm keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLB: